Meyka Pro banner
Neogen Corporation

Neogen Corporation Fundamental Analysis (NASDAQ: NEOG)

NEOGNASDAQ
HealthcareMedical - Diagnostics & Research
$11.40
$0.41(3.47%)
U.S. Market opens in 13h 54m

Neogen Corporation Fundamental Analysis (NASDAQ: NEOG)

Neogen Corporation (NASDAQ: NEOG) shows weak financial fundamentals with a PE ratio of -345.79, profit margin of -0.91%, and ROE of -0.37%. The company generates $0.9B in annual revenue with weak year-over-year growth of -3.20%.

Key Strengths

PEG Ratio-1.80
Current Ratio3.82

Areas of Concern

ROE-0.37%
Operating Margin-2.49%
We analyze NEOG's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 22.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
22.2/100

We analyze NEOG's fundamental strength across five key dimensions:

Efficiency Score

Weak

NEOG struggles to generate sufficient returns from assets.

ROA > 10%
-0.24%

Valuation Score

Excellent

NEOG trades at attractive valuation levels.

PE < 25
-345.79
PEG Ratio < 2
-1.80

Growth Score

Weak

NEOG faces weak or negative growth trends.

Revenue Growth > 5%
-3.20%
EPS Growth > 10%
-114.63%

Financial Health Score

Excellent

NEOG maintains a strong and stable balance sheet.

Debt/Equity < 1
0.38
Current Ratio > 1
3.82

Profitability Score

Weak

NEOG struggles to sustain strong margins.

ROE > 15%
-37.47%
Net Margin ≥ 15%
-0.91%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is NEOG Expensive or Cheap?

P/E Ratio

NEOG trades at -345.79 times earnings. This suggests potential undervaluation.

-345.79

PEG Ratio

When adjusting for growth, NEOG's PEG of -1.80 indicates potential undervaluation.

-1.80

Price to Book

The market values Neogen Corporation at 1.19 times its book value. This may indicate undervaluation.

1.19

EV/EBITDA

Enterprise value stands at 11.02 times EBITDA. This signals the market has high growth expectations.

11.02

How Well Does NEOG Make Money?

Net Profit Margin

For every $100 in sales, Neogen Corporation keeps $-0.91 as profit after all expenses.

-0.91%

Operating Margin

Core operations generate -2.49 in profit for every $100 in revenue, before interest and taxes.

-2.49%

ROE

Management delivers $-0.37 in profit for every $100 of shareholder equity.

-0.37%

ROA

Neogen Corporation generates $-0.24 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.24%

Following the Money - Real Cash Generation

Operating Cash Flow

Neogen Corporation generates limited operating cash flow of $83.34M, signaling weaker underlying cash strength.

$83.34M

Free Cash Flow

Neogen Corporation produces free cash flow of $31.95M, offering steady but limited capital for shareholder returns and expansion.

$31.95M

FCF Per Share

Each share generates $0.15 in free cash annually.

$0.15

FCF Yield

NEOG converts 1.28% of its market value into free cash.

1.28%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-345.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.80

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.88

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.38

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.82

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How NEOG Stacks Against Its Sector Peers

MetricNEOG ValueSector AveragePerformance
P/E Ratio-345.7930.38 Better (Cheaper)
ROE-0.37%474.00% Weak
Net Margin-0.91%-25173.00% (disorted) Weak
Debt/Equity0.380.74 Strong (Low Leverage)
Current Ratio3.825.28 Strong Liquidity
ROA-0.24%2904318.00% Weak

NEOG outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Neogen Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

3.67%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

-989.73%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-67.14%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ